NOVEL PYRIMIDINE CARBOXAMIDES

The present invention relates to novel compounds of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and compositions, their metabolites and prodrugs there...

Full description

Saved in:
Bibliographic Details
Main Authors PARAMESWARAN, VENKATESAN, REDDY, GADDAM, OM, RAJAGOPAL, SRIRAM, TADIPARTHI, RAVIKUMAR, AGGARWAL, PAWAN, THIRUNAVUKKARASU, SAPPANIMUTHU, BARIK, RAJIB
Format Patent
LanguageEnglish
French
German
Published 01.06.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:The present invention relates to novel compounds of the general formula (I), their derivatives, their analogs, their tautomeric forms, their stereoisomers, their polymorphs, their hydrates, their solvates, their pharmaceutically acceptable salts and compositions, their metabolites and prodrugs thereof. The present invention more particularly relates to novel pyrimidine carboxamides of the general formula (I). Also included is a method of prophylaxis or treatment of a pain disorder, immunological diseases, inflammation, rheumatoid arthritis; osteoporosis; multiple myeloma; uveititis; acute and chronic myelogenous leukemia; ischemic heart disease; atherosclerosis; cancer; ischemic-induced cell damage; pancreatic beta cell destruction; osteoarthritis; rheumatoid spondylitis; gouty arthritis; inflammatory bowel disease; adult respiratory distress syndrome (ARDS); psoriasis; Crohn's disease; allergic rhinitis; ulcerative colitis; anaphylaxis; contact dermatitis; muscle degeneration; cachexia; asthma; bone resorption diseases; ischemia reperfusion injury; brain trauma; multiple sclerosis; sepsis; septic shock; toxic shock syndrome; fever, and myalgias due to infection in a mammal comprising administering an effective amount of a compound of formula (I) as described above.
Bibliography:Application Number: EP20060795441